Business News • PR NewsWire • Vigilant Biosciences Receives CE Mark for OncAlert™ Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer

Vigilant Biosciences Receives CE Mark for OncAlert™ Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer

Vigilant Biosciences Receives CE Mark for OncAlert™ Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer

FORT LAUDERDALE, Fla., Nov. 16, 2015 /PRNewswire/ -- Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has CE Marked its OncAlert™ Oral Cancer CD44/Total Protein...

View More : http://www.prnewswire.com/news-releases/vigilant-biosciences-receives-ce-mark-for-oncalert-oral-cancer-cd44total-protein...

Releted News by prnewswire

Estudo internacional induz a reavaliação do aumento do diabetes em cidades

"Beneficios clave de una solución móvil y lista para la nube para las tiendas físicas", explicado por el Head de IT de Decathlon India y el CEO de Openbravo

Nomad Digital Establishes 10-year Partnership with ÖBB (Austrian Federal Railways)

Vigilant Biosciences Receives CE Mark for OncAlert™ Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer